"OncoLens' focus on not just delivering insights but usability tools such as provider targeted alerts, continues to excite us along with their already impressive growth." Mark Buffington, @bipventures We're thrilled to be part of the B group..the Series B group. We count our lucky stars by the number of cancer patient lives we can touch and we look forward to achieving even more major milestones alongside our wonderful customers. Link: oncolens.com/news/oncology-h…

Looking forward to discussing the latest data on Functional Precision Medicine Assays for high grade glioma. Tune in February 12 at noon EST. @KIYATEC @OncoLens Register below: oncolens.zoom.us/webinar/reg…

Congratulations to #VA2018 & #VA2019 alumni company @OncoLens on securing $16M in Series B funding! 🎉 prweb.com/releases/oncology-…

It's Friday ‘Fund’ Day! We have funding news from GA-based oncology health tech startup @OncoLens, North Carolina-based audio tech company, @BrainTapTech, and more: buff.ly/4e1eqch

Join us at the @ACCCBuzz Annual NOC Conference Stop by Booth 623 and learn how The OncoLens Research Network offers relevant, highly curated industry-sponsored initiatives, like clinical trials and disease-specific QIP’s, including innovative programs targeted to improve biomarker testing compliance to guidelines. We look forward to seeing you this week!

We are excited to announce OncoLens' recognition by @inc5000 as one of the Fastest-Growing Private Companies in America, for the second year in a row! inc.com/inc5000/2024

It's critical to wait for biomarker results before starting treatment for lung cancer - how do we balance that with the urgency to start treatment quickly? Advice from patient advocate Aurora Lucas & Drs. Mark Kris & @TurgemanIlit in this @IASLC podcast. iaslc.org/iaslc-news/lung-ca…

New Study on the Benefits of Cancer Survivorship Care @TimMullettMD, thoracic surgeon at @UKMarkey and chair of the @AmColSurgCancer (#ACS) Commission on Cancer (#CoC), co-authored a groundbreaking study on the value of cancer survivorship care standards. This research underscores the importance of structured care programs for cancer survivors, aiming to enhance their quality of life and long-term health outcomes. The study highlights: - Improved patient outcomes with standardized care - The need for comprehensive follow-up plans - Strategies for integrating survivorship care into clinical practice and multidisciplinary collaboration Read more about this significant advancement in cancer care: Markey physician co-authors study on value of cancer survivorship care standards: uknow.uky.edu/research/marke… and the full study here - JAMA Network Open: jamanetwork.com/journals/jam… #SurvivorshipCare #MultidisciplinaryCancerCare #HealthcareInnovation #MedicalResearch

There is still time to register for the final session of the Project ECHO tele-mentoring series on bispecific antibodies and care coordination. Earn 1.0 CME, CPE, or CNE credit when you complete the session. Register now at bit.ly/3wno9cx. Powered by @OncoLens

.@TimMullettMD presents data on CoC BeyondASK, JustASK smoking cessation projects on patient support and treatment strategies, impacting over 1 million patients nationwide. @ASCO #ASCO24 @AmCollSurgeons @ResearchKY @UKMarkey @UKSurgeryDept

.@UKMarkey Thoracic Surgeon, Timothy Mullett, MD, presents on results from the smoking cessation, Beyond ASK CoC initiative at #ACSO24 @ACSO @ResearchKY @TimMullettMD @AmCollSurgeons meetings.asco.org/abstracts-…

.@UKMarkey Medical oncologist Ralph Zinner, MD presents on a clinical trial targeting stage IIIA-C non-small cell #lungcancer (NSCLC) at #ACSO24 @ACSO @ResearchKY meetings.asco.org/abstracts-…

#ASCO24 #LAURA I’m putting this 👏standing ovation video out here for all the patients and investigators who participated in this practice changing study. ➡️ But, let’s all remember that we can’t celebrate until all patients get #biomarkertesting and access to these life-saving drugs in a more cost-effective way #GlobalOnc #lcsm @EGFRResisters @YoungLungCancer

Great meeting with the team at @OncoLens to discuss potential collaboration with the @WIN_Consortium

Some of my quick mid-conference takes on the insane volume of lung cancer data generated during an eventful #ASCO24! [THREAD]

How do we bring interventions like this to the general Multidisciplinary Cancer Care team. Visit the @OncoLens team booth 25149 #ASCO24

Inspiring evening at a celebration of @ASCO @ConquerCancerFd 25th anniversary with half a billion dollars raised since 1999. #ASCO24